DR info

臨床試験数 : 8 / 薬物数 : 10 - (DrugBank : 9) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 101

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Abatacept
   Benaroya Research Institute
      2011   Phase 1   NCT01272856   United States;
Ciclosporin
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan;
DIMENSION
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan;
Infliximab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
Methotrexate
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan;
Rituximab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
Tiotropium
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan;
Tocilizumab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
   Children's Hospital of Eastern Ontario
      2010   -   NCT01041248   Canada;
   McMaster Children's Hospital
      2010   Phase 2   NCT01104480   Canada;